OAK STREET HEALTH, INC.

(OSH)
  Report
Delayed Nyse  -  04:00 2022-08-09 pm EDT
29.27 USD   -2.30%
10:26aOAK STREET HEALTH : Opens Ninth Center in North Carolina
PU
07:06aINSIDER SELL : Oak Street Health
MT
08/08Barclays Raises Oak Street Health's Price Target to $34 From $31, Maintains Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Oak Street Health : Corporate Presentation

08/05/2022 | 07:36am EDT

Corporate Presentation

August, 4 2022

Disclaimer

This presentation contains forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. All statements other than statements of historical facts contained in this presentation, including information concerning our possible or assumed future results of operations and expenses, business strategies and plans, competitive position, business and industry environment (including the effect of the COVID-19 pandemic) and potential growth opportunities, are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including those set out under "Risk Factors" in our annual report on Form 10-K. Given these uncertainties, you should not place undue reliance on any forward- looking statements in this presentation. Except as required by law, we disclaim any obligation to update any forward-looking statements for any reason after the date of this presentation, or to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future.

This presentation includes information concerning economic conditions, the Company's industry, the Company's markets and the Company's competitive position that is based on a variety of sources, including information from independent industry analysts and publications, as well as the Company's own estimates and research. The

The Company's estimates are derived from publicly available information released by third party sources, as well as data from its internal research, and are based on such data and the Company's knowledge of its industry, which the Company believes to be reasonable. The independent industry publications used in this presentation were not prepared on the Company's behalf. While the Company is not aware of any misstatements regarding any information in this presentation, forecasts, assumptions, expectations, beliefs, estimates and projects involve risk and uncertainties and are subject to change based on various factors.

This presentation includes patient contribution, platform contribution and adjusted EBITDA figures. These are non-GAAP figures and are not prepared in accordance with, and are not an alternative for metrics prepared in accordance with, U.S. generally accepted accounting principles and may be different from similar statistics used by other companies. Please refer to the definition of patient contribution, platform contribution, and adjusted EBITDA included in this presentation and to the reconciliations of patient contribution, platform contribution, and adjusted EBITDA to gross profit and net loss included in the Appendix to this presentation.

Introduction to Oak Street Health

We are a patient-centric network of primary care centers for Medicare- eligible patients

We leverage the Oak Street Health platform to provide comprehensive care for our patient population

144

Oak Street owned and operated centers

20

States currently covered

134K

At-risk patients receiving our care

We improve experiences and outcomes for our patients

We reduce hospitalizations by over 50% and retain the savings generated by our care model

$524m

Total 2nd quarter 2022 revenue , 48% annual revenue growth

~5,300

Team members, all aligned with our mission & vision, including ~500 primary care providers

Data as of 06/30/2022

Oak Street Health is deeply committed to equity and inclusion in all facets of our work:

With Our Patients

Within Our Workforce

Recognized as a Great

Place to Work

>50%

of patients identify as African American, Latino or Indigenous

71%

racial minority workforce at OSH vs 38% in U.S. healthcare

42%

of patients are dually eligible for Medicare and Medicaid

~50%

of patients have a housing, food, or isolation risk factor

59%

racial minority providers at OSH vs 45% in U.S. healthcare

58%

female managers at OSH vs 40% in U.S. management positions

Data as of 12/31/2021

Our patient base is complex and requires a multi-dimensional care model

68>90%

average age

of centers are in medically

underserved census tracts

7+

average number of medications

100%

of counties served are designated mental health provider shortage areas

86%

of patients have one or more chronic conditions

Oak Street Health invested nearly $350M in our care centers and their communities in 2021

Data as of 12/31/2021

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Oak Street Health Inc. published this content on 04 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 August 2022 11:35:11 UTC.


© Publicnow 2022
All news about OAK STREET HEALTH, INC.
10:26aOAK STREET HEALTH : Opens Ninth Center in North Carolina
PU
07:06aINSIDER SELL : Oak Street Health
MT
08/08Barclays Raises Oak Street Health's Price Target to $34 From $31, Maintains Overweight ..
MT
08/05OAK STREET HEALTH : Corporate Presentation
PU
08/04INSIDER SELL : Oak Street Health
MT
08/04INSIDER SELL : Oak Street Health
MT
08/04INSIDER SELL : Oak Street Health
MT
08/04JPMorgan Adjusts Price Target for Oak Street Health to $36 From $32, Maintains Overweig..
MT
08/04SVB Securities Adjusts Price Target on Oak Street Health to $32 From $23, Maintains Mar..
MT
08/03UBS Adjusts Oak Street Health Price Target to $28 From $26, Maintains Neutral Rating
MT
More news
Analyst Recommendations on OAK STREET HEALTH, INC.
More recommendations
Financials (USD)
Sales 2022 2 140 M - -
Net income 2022 -515 M - -
Net Debt 2022 729 M - -
P/E ratio 2022 -13,2x
Yield 2022 -
Capitalization 7 066 M 7 066 M -
EV / Sales 2022 3,64x
EV / Sales 2023 2,60x
Nbr of Employees 5 300
Free-Float 90,5%
Chart OAK STREET HEALTH, INC.
Duration : Period :
Oak Street Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OAK STREET HEALTH, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 29,27 $
Average target price 31,78 $
Spread / Average Target 8,57%
EPS Revisions
Managers and Directors
Michael T. Pykosz Chairman & Chief Executive Officer
Brian Clem President & Chief Operating Officer
Timothy Cook Chief Financial Officer
Griffin Myers Director & Chief Medical Officer
David R. Buchanan Chief Clinical Officer
Sector and Competitors
1st jan.Capi. (M$)
OAK STREET HEALTH, INC.-11.68%7 232
CVS HEALTH CORPORATION-1.12%133 909
HCA HEALTHCARE, INC.-17.17%60 660
LABORATORY CORPORATION OF AMERICA HOLDINGS-18.95%23 125
QUEST DIAGNOSTICS-19.44%16 327
REDE D'OR SÃO LUIZ S.A.-19.76%13 864